Our data suggest that IL-17 originates from TH17 cells but not other cell types and plays a protective role in maintaining the balance between the intestinal barrier and gut microbiota, which is closely related to the development of NAFLD/NASH. This evidence concerns the gene IL17A and metabolic dysfunction-associated steatotic liver disease.